Pages that link to "Q15757113"
Jump to navigation
Jump to search
The following pages link to Hemodialysis International (Q15757113):
Displaying 50 items.
- Vascular calcification in end-stage renal disease (Q27009551) (← links)
- Health numeracy: perspectives about using numbers in health management from African American patients receiving dialysis (Q27349561) (← links)
- Acute hemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal hemoperfusion (Q28248969) (← links)
- Insights into nephrologist training, clinical practice, and dialysis choice (Q30224851) (← links)
- Safety of intravenous iron in hemodialysis patients (Q30234981) (← links)
- Management of coronary artery disease and acute coronary syndrome in the chronic kidney disease population-A review of the current literature (Q30238977) (← links)
- Hyponatremia in patients with chronic kidney disease (Q30249295) (← links)
- Recent advances in CKD and ESRD: A literature update (Q30275339) (← links)
- Younger black patients have a higher risk of infection mortality that is mostly non-dialysis related: A national study of cause-specific mortality among U.S. maintenance dialysis patients (Q30276101) (← links)
- Catheter-related bacteremia and mortality in frequent nocturnal home hemodialysis (Q30300867) (← links)
- Plasma vitamin C levels in ESRD patients and occurrence of hypochromic erythrocytes. (Q30313877) (← links)
- Effects of music on complications during hemodialysis for chronic renal failure patients. (Q30360617) (← links)
- Where philosophy meets clinical science (Q30400649) (← links)
- Cromolyn sodium: a potential therapy for uremic pruritus? (Q30440242) (← links)
- Catheter lock heparin concentration: effects on tissue plasminogen activator use in tunneled cuffed catheters (Q30442749) (← links)
- Glucose in the dialysate: historical perspective and possible implications? (Q30445919) (← links)
- Short and long nightly hemodialysis in the United States (Q30446586) (← links)
- Variability in calcium, phosphorus, and parathyroid hormone in patients on hemodialysis (Q30449040) (← links)
- Nightly home hemodialysis: Outcome and factors associated with survival (Q30453126) (← links)
- Superior patient and technique survival with very high standard Kt/V in quotidian home hemodialysis (Q30455419) (← links)
- Phosphorus Clearance Using Two Hemodialyzers Placed in Parallel (Q30460906) (← links)
- A comparison between physicians and computer algorithms for form CMS-2728 data reporting (Q31111183) (← links)
- Development of a new method for monitoring blood purification: the blood flow analysis of the head and foot by laser Doppler blood flowmeter during hemodialysis (Q33224155) (← links)
- Dialyzer reactions in a patient switching from peritoneal dialysis to hemodialysis (Q33368700) (← links)
- Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis (Q33368911) (← links)
- Heparin-induced thrombocytopenia: an uncommon but serious complication of heparin use in renal replacement therapy (Q33371761) (← links)
- Essentials of anticoagulation in hemodialysis (Q33374743) (← links)
- Low-molecular-weight heparin for routine hemodialysis (Q33381414) (← links)
- Anticoagulation options for pediatric hemodialysis (Q33384164) (← links)
- Heparin-induced thrombocytopenia during renal replacement therapy (Q33384167) (← links)
- Initial clinical experience with a new heparin-coated chronic hemodialysis catheter (Q33384677) (← links)
- Linking Centers for Medicare & Medicaid Services data with prospective DCOR trial data: methods and data comparison results (Q33393880) (← links)
- Thrombocytopenia associated with dialysis treatments (Q33395972) (← links)
- Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: nephrologists between two fires. (Q33401438) (← links)
- Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient (Q33403658) (← links)
- Chronic fondaparinux use in a hemodialysis patient with heparin-induced thrombocytopenia type II and extracorporeal circuit thrombosis-a case report and review of the literature (Q33404712) (← links)
- The rationale for the use of low molecular weight heparin for hemodialysis treatments (Q33410982) (← links)
- Heparin-induced thrombocytopenia due to heparin lock in a hemodialysis patient: a case report (Q33412575) (← links)
- A miniseries of spontaneous intramural esophageal hematoma in hemodialysis patients: a rare cause of dysphagia (Q33413804) (← links)
- End-stage renal disease from hemolytic uremic syndrome in the United States, 1995-2010 (Q33420509) (← links)
- Successful use of a bivalirudin treatment protocol to prevent extracorporeal thrombosis in ambulatory hemodialysis patients with heparin-induced thrombocytopenia (Q33427036) (← links)
- Erythropoietic agents, iron and hemoglobin--What happens beyond the trial setting: observational data from the ANZDATA registry (Q33432288) (← links)
- Management of Heparin-Induced Thrombocytopenia During Renal Replacement Therapy (Q33441463) (← links)
- Mechanism and Clinical Presentation of Heparin-Induced Thrombocytopenia (Q33441467) (← links)
- Pitfalls in the Use of Anticoagulants (Q33441493) (← links)
- Rate of creatinine equilibration in whole blood (Q33443357) (← links)
- The carbon footprints of home and in‐center maintenance hemodialysis in the United Kingdom (Q33792523) (← links)
- Tinzaparin reduces health care resource use for anticoagulation in hemodialysis (Q33825694) (← links)
- Measures of blood pressure and cognition in dialysis patients. (Q33826985) (← links)
- Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients (Q33903244) (← links)